Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (20096)	5/5/1998 3:02:00 PM
From: Machaon	Respond to of 32384

This might be an old topic...... But... What's your view on off-label use for Panretin Gel, for other cancers than KS? On another note: Historically, I looked back, using the SI 40 month LGND chart, to see if LGND has ever rallied early in the year, and then rallied again, since LGND had already rallied from $11 to $16 in February of this year. In 1996, LGND rallied from $8 to $14 from 95-DEC thru 96-Jan, and then rallied again from 96-APR thru 96-MAY, from $11 to about $20. Last year was really interesting. LGND was in upward movement from 97-APR thru 97-OCT, from $9 to $19. It sure would be nice for LGND to rally, AND HOLD IT! LGND is neck deep in animal and clinical Cancer developments, and the Cancer hype is all over the news lately. Perhaps, that will give some fuel for a LGND spring/summer rally?! Regards, Bob